Candel Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Candel Therapeutics Total Assets Growth & History (CADL)
Candel Therapeutics's total assets was $125.2M for fiscal 2025.
View full Candel Therapeutics company overviewCandel Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $125.2M | $18.3M | +17.15% |
| 2024 | 2024-12-31 | $106.9M | $65.7M | +159.38% |
| 2023 | 2023-12-31 | $41.2M | −$36.5M | −46.97% |
| 2022 | 2022-12-31 | $77.7M | −$11.5M | −12.91% |
| 2021 | 2021-12-31 | $89.2M | $50.9M | +133.02% |
| 2020 | 2020-12-31 | $38.3M | — | — |
Candel Therapeutics quarterly total assets
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $208.1M | $102.2M | +96.43% |
| Q1 2026 | 2026-03-31 | $201.9M | $106.0M | +110.54% |
| Q4 2025 | 2025-12-31 | $125.2M | $18.3M | +17.15% |
| Q3 2025 | 2025-09-30 | $93.6M | $72.1M | +335.00% |
| Q2 2025 | 2025-06-30 | $106.0M | $79.5M | +300.11% |
| Q1 2025 | 2025-03-31 | $95.9M | $64.7M | +207.22% |
| Q4 2024 | 2024-12-31 | $106.9M | $65.7M | +159.38% |
| Q3 2024 | 2024-09-30 | $21.5M | −$28.5M | −57.02% |
| Q2 2024 | 2024-06-30 | $26.5M | −$32.2M | −54.89% |
| Q1 2024 | 2024-03-31 | $31.2M | −$36.0M | −53.57% |
| Q4 2023 | 2023-12-31 | $41.2M | −$36.5M | −46.97% |
| Q3 2023 | 2023-09-30 | $50.1M | −$34.9M | −41.11% |
| Q2 2023 | 2023-06-30 | $58.7M | −$34.6M | −37.08% |
| Q1 2023 | 2023-03-31 | $67.2M | −$34.3M | −33.80% |
| Q4 2022 | 2022-12-31 | $77.7M | −$11.5M | −12.91% |
| Q3 2022 | 2022-09-30 | $85.0M | −$11.0M | −11.41% |
| Q2 2022 | 2022-06-30 | $93.3M | $62.6M | +203.48% |
| Q1 2022 | 2022-03-31 | $101.6M | — | — |
| Q4 2021 | 2021-12-31 | $89.2M | $50.9M | +133.02% |
| Q3 2021 | 2021-09-30 | $96.0M | — | — |
| Q2 2021 | 2021-06-30 | $30.7M | — | — |
| Q4 2020 | 2020-12-31 | $38.3M | — | — |
Candel Therapeutics total assets trends
Over the last five fiscal years, Candel Therapeutics's total assets increased from $38.3M to $125.2M, a change of $86.9M. The latest reported quarter, Q2 2026, shows $208.1M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Candel Therapeutics source filings ↗